Nature Cell Biology, Journal Year: 2019, Volume and Issue: 21(3), P. 338 - 347
Published: Feb. 4, 2019
Language: Английский
Nature Cell Biology, Journal Year: 2019, Volume and Issue: 21(3), P. 338 - 347
Published: Feb. 4, 2019
Language: Английский
Cell Metabolism, Journal Year: 2021, Volume and Issue: 33(12), P. 2329 - 2354
Published: Oct. 8, 2021
Language: Английский
Citations
195Nature Medicine, Journal Year: 2017, Volume and Issue: 24(1), P. 73 - 83
Published: Dec. 11, 2017
Language: Английский
Citations
194FEBS Journal, Journal Year: 2022, Volume and Issue: 290(6), P. 1420 - 1453
Published: Jan. 8, 2022
Alzheimer’s disease (AD) is an age‐associated neurodegenerative disorder with multifactorial etiology, intersecting genetic and environmental risk factors, a lack of disease‐modifying therapeutics. While the abnormal accumulation lipids was described in very first report AD neuropathology, it not until recent decades that lipid dyshomeostasis became focus research. Clinically, lipidomic metabolomic studies have consistently shown alterations levels various classes emerging early stages brains. Mechanistically, discovery research revealed multifaceted interactions between metabolism key pathogenic mechanisms including amyloidogenesis, bioenergetic deficit, oxidative stress, neuroinflammation, myelin degeneration. In present review, converging evidence defining summarized, followed by discussions on which contributes to pathogenesis modifies risk. Furthermore, lipid‐targeting therapeutic strategies, modification their efficacy stage, ApoE status, metabolic vascular profiles, are reviewed.
Language: Английский
Citations
190Cell Host & Microbe, Journal Year: 2023, Volume and Issue: 31(2), P. 173 - 186
Published: Feb. 1, 2023
Language: Английский
Citations
182Nature Cell Biology, Journal Year: 2019, Volume and Issue: 21(3), P. 338 - 347
Published: Feb. 4, 2019
Language: Английский
Citations
180